oxycodone has been researched along with Pain, Breakthrough in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, KV; Sahni, S; Taylor, LF | 1 |
| Evans, T; Nicholas, TA; Sutton, AV; Wysong, A | 1 |
| Amato, F; Ceniti, S; Consoletti, L; Magaldi, D; Mameli, S; Marcassa, C; Notaro, P; Palmieri, V; Pisanu, GM; Vellucci, R | 1 |
| Coma, J; De Sanctis, V; Estivill, P; Ferreras, J; Folch, J; Fuentes, J; Guitart, J; Jiménez, AJ; Moya, J; Rodelas, F; Salazar, R; Sanz, A; Tomás, A; Vargas, MI | 1 |
| Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S | 1 |
| Alarcón, MDL; Cabezón-Gutiérrez, L; Estévez, FV; Jiménez-López, AJ; Martín-Arroyo, JMT; Padrós, MC; Rebollo, MA; Sanz-Yagüe, A | 1 |
| Earl, CQ; Narayana, A; Slevin, KA; Webster, LR; Yang, R | 1 |
| Narayana, A; Passik, SD; Yang, R | 1 |
| Carroll, E; Conroy, L; Curran, HV; Jones, L; Kamboj, SK; Tookman, A | 1 |
| Bertulli, R; Bossi, P; Granata, R; Saita, L | 1 |
| Gajria, KL; Harshaw, Q; Katz, NP; Shillington, AC; Stephenson, JJ | 1 |
| Fang, WX; Li, F; Sima, L; Wu, XM | 1 |
| Alvarez-Jiménez, P; Núñez-Olarte, JM | 1 |
| Davis, MP | 1 |
1 review(s) available for oxycodone and Pain, Breakthrough
| Article | Year |
|---|---|
[Opioid switch and change of route of administration in cancer patients treated by morphine].
Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol | 2018 |
5 trial(s) available for oxycodone and Pain, Breakthrough
| Article | Year |
|---|---|
High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Quality of Life | 2017 |
Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase
Topics: Administration, Buccal; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain Management; Patient Satisfaction; Treatment Outcome; Young Adult | 2013 |
Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
Topics: Administration, Buccal; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Dosage Forms; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Tablets | 2014 |
Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids.
Topics: Affect; Aged; Analgesics, Opioid; Breakthrough Pain; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Memory; Mental Recall; Middle Aged; Morphine; Neoplasms; Neuropsychological Tests; Oxycodone; Pain | 2014 |
Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial.
Topics: Acetaminophen; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; Double-Blind Method; Drug Combinations; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain; Pain Measurement; Patient Satisfaction; Quality of Life; Treatment Outcome | 2012 |
8 other study(ies) available for oxycodone and Pain, Breakthrough
| Article | Year |
|---|---|
Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
Topics: Acetaminophen; Analgesics, Opioid; Animals; Breakthrough Pain; Buprenorphine; Cattle; Chronic Pain; Female; Humans; Oxycodone; Quality of Life | 2023 |
How We Do It: Postoperative Pain Control in Mohs Micrographic Surgery.
Topics: Acetaminophen; Aged; Analgesics; Anesthesia, Local; Anesthetics, Local; Breakthrough Pain; Celecoxib; Epinephrine; Humans; Lidocaine; Mohs Surgery; Oxycodone; Pain Management; Pain, Postoperative; Pregabalin; Ropivacaine; Vasoconstrictor Agents | 2021 |
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Topics: Administration, Sublingual; Aged; Analgesics, Opioid; Breakthrough Pain; Drug Combinations; Drug Therapy, Combination; Female; Fentanyl; Humans; Male; Naloxone; Neoplasm Staging; Neoplasms; Oxycodone; Pain Management; Quality of Life; Treatment Outcome | 2018 |
Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.
Topics: Administration, Mucosal; Aged; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Central Nervous System Depressants; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Decision Making, Shared; Delphi Technique; Drug Interactions; Fentanyl; Frailty; Geriatric Assessment; Geriatrics; Humans; Medical Oncology; Morphine; Oxycodone; Pain Management; Pain Measurement; Palliative Medicine; Patient Care Team; Practice Guidelines as Topic | 2019 |
Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse.
Topics: Analgesics, Opioid; Breakthrough Pain; Chemoradiotherapy; Coma; Fentanyl; Gastrointestinal Stromal Tumors; Humans; Male; Nasopharyngeal Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Tramadol; Young Adult | 2014 |
Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Sectional Studies; Female; Health Surveys; Humans; Hydrocodone; Independent Living; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Quality of Life; Surveys and Questionnaires; United States | 2017 |
Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.
Topics: Adult; Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; Fatal Outcome; Female; Fentanyl; Humans; Middle Aged; Neoplasms; Opioid-Related Disorders; Ovarian Neoplasms; Oxycodone; Terminal Care | 2011 |
Are there cost benefits to fentanyl for breakthrough pain?
Topics: Administration, Intranasal; Analgesics, Opioid; Breakthrough Pain; Cost-Benefit Analysis; Fentanyl; Humans; Oxycodone; Risk Reduction Behavior | 2012 |